Cargando…
Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions
BACKGROUND: Differentiating multiple pulmonary lesions as multiple primary lung cancer (MLC) or intra-pulmonary metastasis (IPM) is critical. Lung cancer also has a high genetic heterogeneity, which influenced the treatment strategy. Genetic information may aid in tracing lineage information on mult...
Autores principales: | Qiu, Yuan, Liu, Liping, Yang, Haihong, Chen, Hanzhang, Deng, Qiuhua, Xiao, Dakai, Lin, Yongping, Zhu, Changbin, Li, Weiwei, Shao, Di, Jiang, Wenxi, Wu, Kui, He, Jianxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469651/ https://www.ncbi.nlm.nih.gov/pubmed/36110964 http://dx.doi.org/10.3389/fonc.2022.952572 |
Ejemplares similares
-
Integrating Histologic and Genomic Characteristics to Predict Tumor Mutation Burden of Early-Stage Non-Small-Cell Lung Cancer
por: Qiu, Yuan, et al.
Publicado: (2021) -
Assessing tumor heterogeneity: integrating tissue and circulating tumor DNA (ctDNA) analysis in the era of immuno-oncology - blood TMB is not the same as tissue TMB
por: Fridland, Stanislav, et al.
Publicado: (2021) -
Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions
por: Zhang, Xia, et al.
Publicado: (2020) -
A radiomics nomogram prediction for survival of patients with “driver gene-negative” lung adenocarcinomas (LUAD)
por: Guo, Qi-Kun, et al.
Publicado: (2023) -
Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine
por: Hiley, Crispin, et al.
Publicado: (2014)